Related Experiment Video
Updated: Aug 11, 2026
07:50
An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
Published on: January 7, 2019
Pathogenic mechanisms in rheumatic carditis: focus on valvular endothelium
S Roberts1, S Kosanke, Terrence Dunn S
1Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
The Journal of Infectious Diseases
|January 3, 2001
Summary
Immune cells, specifically CD4(+) and CD8(+) T lymphocytes, infiltrate heart valves in rheumatic heart disease. This infiltration, facilitated by VCAM-1 expression on endothelium, is a key step in disease development.
Area of Science:
- Immunology
- Cardiovascular Pathology
- Rheumatic Diseases
Background:
- Rheumatic heart disease (RHD) is a significant cause of acquired heart valve disease.
- The precise immune mechanisms driving RHD pathogenesis remain incompletely understood.
- Group A streptococcal infection is the initiating trigger for RHD.
Purpose of the Study:
- To elucidate the immune-mediated mechanisms involved in RHD.
- To investigate the role of T lymphocytes and VCAM-1 in RHD valve pathology.
- To identify potential initiating steps in RHD pathogenesis.
Main Methods:
- Analysis of valve tissues from RHD patients undergoing valve replacement.
- Immunohistochemical staining using monoclonal antibodies against CD4, CD8, and VCAM-1.
- Assessment of lymphocyte adhesion and infiltration through valvular endothelium.
Main Results:
- CD4(+) and CD8(+) T lymphocytes were found adherent to and penetrating the valvular endothelium.
- VCAM-1 was expressed on the valvular endothelium of affected valves.
- Evidence indicated T cell extravasation through activated endothelium as a critical event.
Conclusions:
- T cell extravasation via VCAM-1-expressing valvular endothelium is a crucial step in RHD pathogenesis.
- Lymphocytic infiltration through the valve surface endothelium is a newly appreciated initiating factor in RHD.
- Understanding these mechanisms may inform future therapeutic strategies for RHD.
Related Concept Videos
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
01:25Endocarditis I: Introduction
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
01:21Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...